LeafBio created ZMapp in collaboration with its parent and Defyrus Inc., each of which had developed its own cocktail of antibodies, called MB-003 and ZMab.
mAbs) в составе препарата были взяты из комбинации антител ZMAb (получена Defyrus/PHAC), а третье из MB-003 (получено Mapp).